Résultats de recherche avancée du registre

Critères de recherche

Nom du TCPD : CHADWICK, MICHELE

Partager la recherche Créer une alerte

Retour à la recherche

Modifier les critères

Si vous souhaitez voir un sommaire des 12 derniers mois pour une activité de lobbying, utilisez la Recherche de 12 mois d'activités de lobbying

Rapports mensuels de communications (3)

Résultats : 1-3 | Exporter

Forum canadien des biosimilaires / Canadian Biosimilars Forum
Type : Lobbyiste-conseil
Lobbyiste : Ross Wallace, Santis Health

A eu lieu : 2018-05-22
Publié : 2018-06-15
Titulaires de charge publique désignée :
- Jian Wang, Division Chief, Health Products and Therapeutics Branch | Santé Canada (SC)
- Stephanie Hardy, Manager, Policy Unit, Health Products and Therapeutics Branch | Santé Canada (SC)
- Lindsay Elmgren, Director, Centre for Biologics Evaluation, Health Products and Therapeutics Branch | Santé Canada (SC)
- Agnes Klein, Senior Medical Advisor, Health Products and Therapeutics Branch | Santé Canada (SC)
- Jemma Fraije, A/ Regulatory Affairs Supervisor, Health Products and Therapeutics Branch | Santé Canada (SC)
- Emily Griffiths, Subject Matter / Technical Specialist, Health Products and Therapeutics Branch | Santé Canada (SC)
- Michele Chadwick, Manager, Health Products and Therapeutics Branch | Santé Canada (SC)
- Cathy Parker, Director General, Health Products and Therapeutics Branch | Santé Canada (SC)
- Evelyn Soo, Associate to the Director General, Health Products and Therapeutics Branch | Santé Canada (SC)
- Megan Bettle, Director, Health Products and Therapeutics Branch | Santé Canada (SC)
- Georgette Roy, Director, Office of Regulatory Affairs, Health Products and Therapeutics Branch | Santé Canada (SC)
- Karen Reynolds, Executive Director, Strategic Policy Branch | Santé Canada (SC)
- Johanne Veenstra, Senior Regulatory Officer, Health Products and Therapeutics Branch | Santé Canada (SC)
- Anthony Ridgway, Senior Regulatory Scientist, Health Products and Therapeutics Branch | Santé Canada (SC)
- Kelly Robinson, Director, Health Products and Therapeutics Branch | Santé Canada (SC)
- Liz Anne Gillham-Eisen, A Director, Health Products and Therapeutics Branch | Santé Canada (SC)
Objets :
Forum canadien des biosimilaires / Canadian Biosimilars Forum
Type : Lobbyiste-conseil
Lobbyiste : Ross Wallace, Santis Health

A eu lieu : 2017-11-21
Publié : 2018-01-17
Titulaires de charge publique désignée :
- Laura Johnson, SBD Project Manager, THERAPEUTIC PRODUCTS DIRECTORATE | Santé Canada (SC)
- Michele Chadwick, Manager, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Santé Canada (SC)
- Parag Buch, Subject Matter Technical Special, MARKETED HEALTH PRODUCTS DIRECTORATE | Santé Canada (SC)
- Wallace Lauzon, Division Chief, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Santé Canada (SC)
- Sandra Alderdice, Regulatory Affairs Supervisor, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Santé Canada (SC)
- Liz Anne Gillham-Eiosen, A Director, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Santé Canada (SC)
- Andrea Bedard, Policy Analyst, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Santé Canada (SC)
- Cathy Parker, Director General, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Santé Canada (SC)
- Georgette Roy, Director, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Santé Canada (SC)
- Agnes Klein, Senior Medical Advisor, DGO, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Santé Canada (SC)
- Jian Wang, Division Chief, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Santé Canada (SC)
- Stephanie Hardy, Manager, Policy Unit, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Santé Canada (SC)
- Anthony Ridgway, Acting Director, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Santé Canada (SC)
- Alain Musende, Manager, MARKETED HEALTH PRODUCTS DIRECTORATE | Santé Canada (SC)
- Jeffrey Skene, Division Chief, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Santé Canada (SC)
Objets :
Forum canadien des biosimilaires / Canadian Biosimilars Forum
Type : Lobbyiste-conseil
Lobbyiste : Ross Wallace, Santis Health

A eu lieu : 2017-06-09
Publié : 2017-08-04
Titulaires de charge publique désignée :
- Stephanie Hardy, Manager, Policy Unit, Health Products and Food Branch | Santé Canada (SC)
- Deryck Trehearne, Director General, Health Products and Food Branch | Santé Canada (SC)
- Wallace Lauzon, Division Chief, Health Products and Food Branch | Santé Canada (SC)
- Agnes Klein, Senior Medical Advisor, Health Products and Food Branch | Santé Canada (SC)
- Georgette Roy, Director, Office of Regulatory Affairs, Health Products and Food Branch | Santé Canada (SC)
- Cathy Parker, Director General, Health Products and Food Branch | Santé Canada (SC)
- Trish Larwill, Senior Policy Advisor, Health Products and Food Branch | Santé Canada (SC)
- Jian Wang, Division Chief, Health Products and Food Branch | Santé Canada (SC)
- Michele Chadwick, Manager, Health Products and Food Branch | Santé Canada (SC)
- Catherine Njue, Biostatistician Advisor - Clinical Trials, Health Products and Food Branch | Santé Canada (SC)
- Emily Griffiths, Policy Analyst, Health Products and Food Branch | Santé Canada (SC)
- Liz Anne Gillham-Eisen, A/Director, Health Products and Food Branch | Santé Canada (SC)
- Anthony Ridgway, Acting Director, Health Products and Food Branch | Santé Canada (SC)
- Ashley Baer, Policy Analyst, Health Products and Food Branch | Santé Canada (SC)
- Sandra Alderdice, Regulatory Affairs Supervisor, Health Products and Food Branch | Santé Canada (SC)
- Jeffrey Skene, Division Chief, Health Products and Food Branch | Santé Canada (SC)
- Laura Johnson, SBD Project Manager, Health Products and Food Branch | Santé Canada (SC)
- Nick Orphanos, Senior Policy Analyst, Health Products and Food Branch | Santé Canada (SC)
Objets :

Date de la dernière version :: 2024-04-04

Recherche et menus

Sélection de la langue

Résultats de recherche avancée du registre

Critères de recherche

Affiner les résultats des enregistrements par

Affiner les résultats des rapports de communication mensuels par